You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HSPC

Showing 1 - 25 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • CD33KO-HSPC; CART33
  • (no location specified)
Jul 13, 2023

(LTFU) of Patients Treated With Genome-edited Autologous

Not yet recruiting
  • Sickle Cell Disease
  • OTQ923
  • (no location specified)
Nov 24, 2023

HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)

Active, not recruiting
  • HIV
  • SB-728mR-HSPC Infusion 3 days following busulfan conditioning
  • Duarte, California
  • +4 more
Mar 7, 2022

Prostate Cancer, Stereotactic Body Radiation Therapy Trial (SBRT, STANDARD OF CARE)

Not yet recruiting
  • Prostate Cancer
  • Stereotactic Body Radiation Therapy
  • SBRT
  • STANDARD OF CARE
  • (no location specified)
Jan 25, 2022

Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic

Not yet recruiting
  • Adenosine Deaminase Severe Combined Immune Deficiency
  • A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
  • (no location specified)
Jun 20, 2022

Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

Recruiting
  • Transfusion Dependent Beta Thalassemia
  • +3 more
  • EDIT-301
  • Oakland, California
  • +3 more
Jan 3, 2023

Acquired Brain Injury Trial in Glasgow, Paisley (ApplTree, Google Calendar)

Recruiting
  • Acquired Brain Injury
  • ApplTree
  • Google Calendar
  • Glasgow, Dunbartonshire, United Kingdom
  • +3 more
Oct 20, 2022

Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

Not yet recruiting
  • Lymphoid Leukemia
  • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
  • Treg CD34+ HSPC (Orca-T)
  • Palo Alto, California
    Stanford Cancer Center
Aug 17, 2022

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Human Immunodeficiency Virus Trial in Los Angeles, San Francisco (Busulfan, Cal-1 modified HSPC, Cal-1 modified CD4+ T

Completed
Has Results
  • Human Immunodeficiency Virus
  • Los Angeles, California
  • +1 more
Jul 22, 2020

Prostate Cancer Trial in Uppsala (No intervention)

Completed
  • Prostate Cancer
  • No intervention
  • Uppsala, Sweden
    Site SE46001
Jan 30, 2020

Lysosomal Storage Diseases, Metachromatic Leukodystrophy Trial in Milan (OTL-200)

Recruiting
  • Lysosomal Storage Diseases
  • Metachromatic Leukodystrophy
  • OTL-200
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 16, 2022

Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)

Recruiting
  • Sickle Cell Disease
  • OTQ923
  • Los Angeles, California
  • +4 more
Jan 9, 2023

AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

Active, not recruiting
  • AIDS-Related Burkitt Lymphoma
  • +5 more
  • Bethesda, Maryland
    NCI Lymphoid Malignancies Branch
Jul 31, 2022

Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

Recruiting
  • Chronic Granulomatous Disease X-linked (X-CGD)
  • Rome, Lazio, Italy
  • +1 more
Oct 27, 2022

Clinical Specimen Collection From Pompe Disease Patients

Recruiting
  • Pompe Disease
  • Toluca Lake, California
    Seraph Research Institute
May 17, 2022

Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • La Jolla, California
  • +8 more
Jan 31, 2023

Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

Active, not recruiting
  • Sickle Cell Disease
  • GPH101 Drug Product
  • Birmingham, Alabama
  • +2 more
Jan 5, 2023

Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

Recruiting
  • Myelodysplastic Syndromes
  • Blood test
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Nov 27, 2023

Sickle Cell Disease Trial in United States (biological, drug, genetic)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • +2 more
  • Oakland, California
  • +5 more
Sep 13, 2022

AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte

Active, not recruiting
  • AIDS-related Non-Hodgkin Lymphoma
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Learn More About How Radium-223 is Being Used With Other

Active, not recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium 223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Denmark
  • +2 more
Jan 16, 2023

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Dresden, Heidelberg (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion
  • Gemtuzumab Ozogamicin
  • Dresden, Germany
  • +1 more
Dec 20, 2022

Pathological Myeloid Activation After Sepsis and Trauma

Recruiting
  • Trauma Injury
  • +3 more
  • Data Collection
  • +3 more
  • Gainesville, Florida
    UF Health at Shands Hospital
Jan 19, 2023

Discrimination, Social, Health Care Utilization Trial in Los Angeles (CBT Coping Intervention)

Recruiting
  • Discrimination, Social
  • Health Care Utilization
  • CBT Coping Intervention
  • Los Angeles, California
    APLA Health
Oct 12, 2022